GNH USA

Europe — EMA

Lanthanum Viatris

GNH USA supplies Lanthanum Viatris (Lanthanum), a phosphate binder for hyperphosphatemia in dialysis patients. Request a quote for global and reliable supply.

Lanthanum

Request sourcing

1
Pack/s

What is Lanthanum?

Lanthanum, the active ingredient in Lanthanum Viatris, is a phosphate binder presented as an oral formulation for oral use. It is employed to treat hyperphosphatemia in patients with chronic kidney disease who are receiving dialysis. The drug binds dietary phosphate in the gastrointestinal tract, creating insoluble complexes that are excreted, thereby lowering serum phosphate levels.

GNH USA supplies Lanthanum Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

What is Lanthanum used for?

Lanthanum Viatris is a phosphate binder indicated for conditions associated with elevated serum phosphate.

- Hyperphosphatemia in chronic kidney disease on dialysis: reduces serum phosphate levels by binding dietary phosphate. - End‑stage renal disease (ESRD) patients: helps maintain phosphate balance to prevent vascular calcification. - Chronic kidney disease (CKD) not yet on dialysis (when prescribed): lowers phosphate absorption to support renal management.

What are the side effects of Lanthanum?

Lanthanum may cause gastrointestinal and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild stomach upset. - Constipation: reduced bowel movements. - Abdominal pain: discomfort in the abdomen. - Diarrhea: loose stools.

Serious or Rare Side Effects: - Severe constipation or bowel obstruction: may require medical attention. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hypercalcemia: elevated calcium levels in rare cases.

What precautions apply to Lanthanum?

When prescribing Lanthanum, clinicians should consider several safety precautions to minimize risks. - Monitor serum phosphate: regularly check levels to adjust dose. - Assess calcium and magnesium: avoid imbalances that could lead to complications. - Avoid use in patients with bowel obstruction: risk of worsening blockage. - Caution in pregnancy and lactation: limited data, weigh benefits versus risks. - Drug interactions: separate administration from other oral phosphate binders or mineral supplements by at least 2 hours. - Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture.

What does Lanthanum interact with?

Lanthanum can affect the absorption of other oral medications, leading to clinically relevant interactions.

Major Interactions (Avoid): - Other phosphate binders (e.g., sevelamer, calcium carbonate): concurrent use reduces efficacy of both agents. - Iron supplements (ferrous sulfate): lanthanum markedly decreases iron absorption.

Moderate Interactions (Monitor Closely): - Tetracycline antibiotics (doxycycline): reduced antibiotic absorption; separate dosing by at least 2 hours. - Fluoroquinolone antibiotics (ciprofloxacin): decreased bioavailability; stagger administration. - Vitamin D analogs (calcitriol): may increase calcium absorption; monitor calcium levels.

Frequently asked questions

What is Lanthanum Viatris used for?+
Lanthanum Viatris is prescribed to manage hyperphosphatemia, a condition of elevated serum phosphate, in patients with chronic kidney disease who are receiving dialysis. By lowering phosphate absorption from the diet, it helps reduce the risk of complications such as vascular calcification associated with kidney failure.
How does lanthanum work?+
Lanthanum binds phosphate ions within the gastrointestinal tract, forming insoluble lanthanum‑phosphate complexes that are not absorbed. These complexes are eliminated in the feces, decreasing the amount of phosphate entering the bloodstream and thereby helping to control serum phosphate levels in patients with impaired renal excretion.
What determines the dose of Lanthanum Viatris?+
The dose of Lanthanum Viatris is individualized by the prescribing clinician based on the patient’s serum phosphate measurements, dietary phosphate intake, and overall renal function. The prescriber adjusts the amount to achieve target phosphate levels while minimizing side effects.
Is Lanthanum Viatris safe in pregnancy or breastfeeding?+
Safety data for lanthanum during pregnancy and lactation are limited. The drug should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians typically evaluate each case carefully and may consider alternative therapies when possible.
How do I order Lanthanum Viatris from GNH USA?+
To order Lanthanum Viatris, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.
How does Lanthanum Viatris compare with other phosphate binders?+
Lanthanum Viatris is an oral, non‑calcium phosphate binder, which can be advantageous for patients at risk of hypercalcemia. Compared with calcium‑based binders, it does not add calcium load, and unlike sevelamer, it does not contain a high amount of polymeric material. Choice of binder depends on individual patient needs, tolerability, and cost considerations.
How should Lanthanum Viatris be stored and handled?+
Lanthanum Viatris should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging to protect it from moisture and light. Do not store in a refrigerator or freezer unless the label specifically indicates otherwise.
How is Lanthanum Viatris administered?+
Lanthanum Viatris is taken orally, usually with meals to maximize phosphate binding. The tablet or powder is swallowed with a sufficient amount of water, and dosing times should be spaced at least two hours apart from other oral medications that may interact with its absorption.
What are the most serious risks associated with Lanthanum Viatris?+
Serious risks include severe constipation or bowel obstruction, which may require medical intervention, and rare allergic reactions that can manifest as rash, swelling, or anaphylaxis. In uncommon cases, lanthanum may contribute to hypercalcemia or liver enzyme abnormalities, so monitoring is advised.
Who should not use Lanthanum Viatris?+
Lanthanum Viatris should be avoided in patients with known hypersensitivity to lanthanum or any component of the formulation, those with active gastrointestinal obstruction, and individuals for whom phosphate binding is contraindicated. Caution is also advised for patients with severe liver disease or those who are pregnant or breastfeeding unless clearly indicated by a physician.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Lanthanum
Route
Oral Use
Manufacturer
Viatris Limited
Origin
EU

Related products

Calafos

Calafos

Lanthanum

Viatris Limited
EU
Calafos

Calafos

Lanthanum

Viatris Limited
EU
Calafos

Calafos

Lanthanum

Viatris Limited
EU
Fosrenol

Fosrenol

Lanthanum

Takeda Pharmaceuticals International Ag Ireland Branch
EU